New Studies Link Rare Blood Clots to Specific COVID-19 Vaccines; AIM Calls for Enhanced Surveillance
May 17, 2024The Awaken India Movement (AIM) has expressed persistent worries regarding adverse events following COVID-19 vaccinations, highlighting recent academic research.
New studies from Banaras Hindu University and Flinders University have reported side effects associated with Covaxin and AstraZeneca's vaccines.
Further research pinpoints that rare blood clots from Johnson & Johnson and AstraZeneca vaccines may be caused by an autoimmune reaction in genetically predisposed individuals.
Incidence rates include 60 cases of blood clots among over 18 million recipients of the J&J vaccine and 2-3 cases per 100,000 AstraZeneca vaccinations in Australians under 60, with some fatalities.
AIM advocates for a governmental reevaluation of the science behind all COVID-19 vaccines and calls for the establishment of rigorous surveillance systems to detect and monitor vaccine-related adverse events.
Summary based on 9 sources
Get a daily email with more Science stories
Sources
The Weather Channel • May 16, 2024
AstraZeneca's COVID-19 Vaccine Linked to Another Rare Blood Clotting Disorder 'VITT': Experts | Weather.comThe Hindu • May 16, 2024
Doctors group raises concerns over Covishield vaccine side effectsEconomic Times • May 16, 2024
Covaxin side effects: What are the symptoms reported in adverse event cases? Should you worry?Outlook India • May 16, 2024
AstraZeneca's Covid-19 Vaccine Can Cause A Second 'Rare' Blood Clotting Disorder? | What Research Says